Agrochemicals company PI Industries announced Q3FY26 results Total Income: Rs 13,757 million against Rs 19,008 million during Q3FY25, change -28%. EBITDA: Rs 3,027 million against Rs 5,122 million during Q3FY25, change -41%. EBITDA Margin: 22% for Q3FY26. PAT: Rs 3,113 million against Rs 3,727 million during Q3FY25, change -16%. The company saw a ~32% decline in Agchem Exports (Volume down ~ 29 %) in line with the customer delivery schedule. Pharma revenue contracted by 6% YoY due to the deferment of supply schedules to Q4FY26. Pharma revenue contributes ~5% of the export revenue. Overheads increase, comprising the strategic development of new businesses and the promotion of new products (6%), offset by effective cost control in existing businesses. The Board has approved an interim dividend for FY25-26 of Rs 5.00 per share. Result PDF
Conference Call with PI Industries Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.